Vanda Pharmaceuticals (VNDA)

$4.74 -0.25 (-5.01%)
Market Cap 279.35M
Revenue (ttm) 198.77M
Net Income (ttm) -18.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9.51%
Debt to Equity Ratio 0.00
Volume 557,300
Avg Vol 460,228
Day's Range N/A - N/A
Shares Out 58.93M
Stochastic %K 17%
Beta 0.68
Analysts Strong Sell
Price Target $12.67

Company Profile

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 202 734 3400
Fax: 202 296 1450
Address:
2200 Pennsylvania Avenue NW, Suite 300E, Washington, United States
Trendrebel
Trendrebel Jul. 13 at 6:21 AM
$VNDA Someone really has something against north of $ 5.
0 · Reply
Texout
Texout Jul. 11 at 6:10 PM
$VNDA spot on. Added 10k so far.
1 · Reply
HorizonBull
HorizonBull Jul. 11 at 5:53 PM
$VNDA opportunity to load cheap again added 2k 4.77
0 · Reply
Trendrebel
Trendrebel Jul. 11 at 4:48 PM
$VNDA My guess / prediction...
0 · Reply
onemillion2012
onemillion2012 Jul. 10 at 2:34 PM
$RXST sold. 20 percent gain on one day beautiful. Do i buy $ASMB or $VNDA
4 · Reply
OJame
OJame Jul. 9 at 10:41 PM
$VNDA I believe that some of their products are meant to be commercially available to public, so they are trying to build credibility and a base.
0 · Reply
HFlier
HFlier Jul. 9 at 6:36 PM
$VNDA Well, well, maybe that buy out is coming.
1 · Reply
Texout
Texout Jul. 9 at 3:39 PM
$VNDA Resistance: begins around $5.20–$5.30. A clear breakout above that opens the next move to $5.50–$5.80. All that is meaningless Pennie’s talk.. imagine this should move in pts not Pennie’s. Be prepared for it. I am!
0 · Reply
Popeye3c
Popeye3c Jul. 9 at 3:26 PM
$VNDA whoahhhhh
0 · Reply
JFDI
JFDI Jul. 9 at 2:57 PM
$VNDA stage 1
0 · Reply
Latest News on VNDA
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

Jun 10, 2025, 8:00 AM EDT - 4 weeks ago

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting

May 27, 2025, 9:00 AM EDT - 6 weeks ago

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

May 16, 2025, 5:30 PM EDT - 2 months ago

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:55 PM EDT - 2 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

May 7, 2025, 4:01 PM EDT - 2 months ago

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026

May 5, 2025, 8:00 AM EDT - 2 months ago

Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026

Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025

May 2, 2025, 8:46 AM EDT - 2 months ago

Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025

FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA

Apr 23, 2025, 3:52 PM EDT - 2 months ago

FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA

Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting

Apr 7, 2025, 8:00 AM EDT - 3 months ago

Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

Mar 31, 2025, 8:00 AM EDT - 3 months ago

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"

Feb 24, 2025, 7:00 AM EST - 4 months ago

Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"

Vanda Pharmaceuticals, Inc. (VNDA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 10:29 PM EST - 5 months ago

Vanda Pharmaceuticals, Inc. (VNDA) Q4 2024 Earnings Call Transcript

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 13, 2025, 4:01 PM EST - 5 months ago

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Feb 5, 2025, 4:30 PM EST - 5 months ago

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis

Jan 27, 2025, 7:00 AM EST - 5 months ago

Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis

Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

Jan 8, 2025, 4:17 PM EST - 6 months ago

Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity

Dec 20, 2024, 1:26 PM EST - 7 months ago

Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

Dec 20, 2024, 9:13 AM EST - 7 months ago

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

Dec 16, 2024, 9:29 PM EST - 7 months ago

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

Nov 12, 2024, 4:58 PM EST - 8 months ago

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 8:20 PM EST - 8 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:02 PM EST - 8 months ago

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

Nov 1, 2024, 2:05 PM EDT - 9 months ago

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024

Oct 30, 2024, 4:30 PM EDT - 9 months ago

Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.

Oct 14, 2024, 10:56 AM EDT - 9 months ago

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.

Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals

Oct 14, 2024, 10:37 AM EDT - 9 months ago

Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

Oct 14, 2024, 8:19 AM EDT - 9 months ago

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

Vanda Pharmaceuticals decries FDA's rejection of stomach paralysis drug as unjust

Sep 19, 2024, 3:17 PM EDT - 10 months ago

Vanda Pharmaceuticals decries FDA's rejection of stomach paralysis drug as unjust

FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies

Sep 19, 2024, 10:33 AM EDT - 10 months ago

FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies

U.S. FDA declines to approve Vanda's stomach paralysis drug

Sep 19, 2024, 7:57 AM EDT - 10 months ago

U.S. FDA declines to approve Vanda's stomach paralysis drug

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Sep 19, 2024, 7:00 AM EDT - 10 months ago

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference

Sep 11, 2024, 5:00 PM EDT - 10 months ago

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Sep 4, 2024, 5:13 PM EDT - 11 months ago

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference

Aug 29, 2024, 4:30 PM EDT - 11 months ago

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference

Vanda Pharmaceuticals: I Believe That The Bidding War Is Not Over

Aug 8, 2024, 2:19 PM EDT - 1 year ago

Vanda Pharmaceuticals: I Believe That The Bidding War Is Not Over

Vanda Pharmaceuticals Inc. (VNDA) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 1:14 PM EDT - 1 year ago

Vanda Pharmaceuticals Inc. (VNDA) Q2 2024 Earnings Call Transcript

Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 31, 2024, 4:01 PM EDT - 1 year ago

Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

Jul 26, 2024, 9:19 AM EDT - 1 year ago

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Jul 1, 2024, 8:01 AM EDT - 1 year ago

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Future Pak withdraws offer to buy Vanda Pharmaceuticals

Jun 26, 2024, 6:27 PM EDT - 1 year ago

Future Pak withdraws offer to buy Vanda Pharmaceuticals

Trendrebel
Trendrebel Jul. 13 at 6:21 AM
$VNDA Someone really has something against north of $ 5.
0 · Reply
Texout
Texout Jul. 11 at 6:10 PM
$VNDA spot on. Added 10k so far.
1 · Reply
HorizonBull
HorizonBull Jul. 11 at 5:53 PM
$VNDA opportunity to load cheap again added 2k 4.77
0 · Reply
Trendrebel
Trendrebel Jul. 11 at 4:48 PM
$VNDA My guess / prediction...
0 · Reply
onemillion2012
onemillion2012 Jul. 10 at 2:34 PM
$RXST sold. 20 percent gain on one day beautiful. Do i buy $ASMB or $VNDA
4 · Reply
OJame
OJame Jul. 9 at 10:41 PM
$VNDA I believe that some of their products are meant to be commercially available to public, so they are trying to build credibility and a base.
0 · Reply
HFlier
HFlier Jul. 9 at 6:36 PM
$VNDA Well, well, maybe that buy out is coming.
1 · Reply
Texout
Texout Jul. 9 at 3:39 PM
$VNDA Resistance: begins around $5.20–$5.30. A clear breakout above that opens the next move to $5.50–$5.80. All that is meaningless Pennie’s talk.. imagine this should move in pts not Pennie’s. Be prepared for it. I am!
0 · Reply
Popeye3c
Popeye3c Jul. 9 at 3:26 PM
$VNDA whoahhhhh
0 · Reply
JFDI
JFDI Jul. 9 at 2:57 PM
$VNDA stage 1
0 · Reply
JazzyJ03
JazzyJ03 Jul. 9 at 2:47 PM
$VNDA ☺️ I’m not going anywhere.
0 · Reply
Popeye3c
Popeye3c Jul. 9 at 2:41 PM
$VNDA come onnn!!!
0 · Reply
Trendrebel
Trendrebel Jul. 9 at 5:23 AM
$VNDA We are still trading well above MA50. But somehow this level above $5 is troubled water - the last +2 years. We need some fundamental news to pass this level.
0 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 9 at 2:11 AM
$VNDA looks like a dog to me. Woof. Talk me out of it 🐕
0 · Reply
HorizonBull
HorizonBull Jul. 8 at 8:11 PM
$VNDA added 2k
0 · Reply
Texout
Texout Jul. 8 at 5:12 PM
$VNDA adding 25k shares as per my message. This is the wrong price in my view and hence I buy it until it’s thw right price
1 · Reply
simonig1
simonig1 Jul. 8 at 4:59 PM
$VNDA Millennium Management opens new 5.3% position in VNDA. Link: https://www.secform4.com/13dg-history/1347178.html
0 · Reply
Popeye3c
Popeye3c Jul. 8 at 2:49 PM
$VNDA BUY THE DIP!!!
0 · Reply
Texout
Texout Jul. 8 at 1:15 PM
$VNDA I remain with the view - this is the wrong price and to me it is a clear buy. I will keep adding. Q2 results, next data point, coming up soon
0 · Reply
HFlier
HFlier Jul. 7 at 8:35 PM
$VNDA This stock makes me feel like I am stuck on fly paper. I just has no enthusiasm and can't move.
0 · Reply
Texout
Texout Jul. 7 at 6:32 PM
$VNDA added 10k 4,93
0 · Reply
Popeye3c
Popeye3c Jul. 7 at 4:29 PM
$VNDA touch $5.06!
0 · Reply